Form 8-K

8-K — 3M CO

Accession: 0001104659-26-106710

Filed: 2026-09-10

Period: 2026-09-10

CIK: 0000066740

SIC: 3841 (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — tm2624999d1_8k.htm (Primary)

EX-1.1 — EXHIBIT 1.1 (tm2624999d1_ex1-1.htm)

EX-4.1 — EXHIBIT 4.1 (tm2624999d1_ex4-1.htm)

EX-4.2 — EXHIBIT 4.2 (tm2624999d1_ex4-2.htm)

EX-4.3 — EXHIBIT 4.3 (tm2624999d1_ex4-3.htm)

EX-5.1 — EXHIBIT 5.1 (tm2624999d1_ex5-1.htm)

GRAPHIC (tm2624999d1_ex5-1img001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2624999d1_8k.htm · Sequence: 1

false

0000066740

2026-09-10

0000066740

us-gaap:CommonStockMember

exch:XNYS

2026-09-10

0000066740

mmm:Notes1.500PercentDue2026Member

exch:XNYS

2026-09-10

0000066740

mmm:Notes1.750PercentDue2030Member

exch:XNYS

2026-09-10

0000066740

mmm:Notes1.500PercentDue2031Member

exch:XNYS

2026-09-10

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):

September 10, 2026

3M COMPANY

(Exact Name of Registrant as Specified in

Its Charter)

Delaware

File No. 1-3285

41-0417775

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

3M Center, St. Paul, Minnesota

55144-1000

(Address of Principal Executive Offices)

(Zip Code)

(Registrant’s Telephone Number, Including

Area Code) (651) 733-1110

Not Applicable

(Former Name or Former Address, if Changed

Since Last Report)

Check the appropriate box below if the Form 8-K filing

is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General

Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under

the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under

the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under

the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under

the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of

the Act:

Title of each class

Trading Symbol(s)

Name

of each exchange on which

registered

Common Stock, Par Value $.01 Per Share

MMM

New York Stock Exchange

MMM

NYSE Texas, Inc.

1.500% Notes due 2026

MMM26

New York Stock Exchange

1.750% Notes due 2030

MMM30

New York Stock Exchange

1.500% Notes due 2031

MMM31

New York Stock Exchange

Note: The common stock of the Registrant is also

traded on the SIX Swiss Exchange.

Securities registered pursuant

to section 12(g) of the Act: None

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange

Act of 1934 (17 CFR §240.12b-2).

Emerging

growth company ¨

If an emerging growth company,

indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised

financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01. Other Events

On September 3, 2026, 3M Company (the “Company”) entered

into an Underwriting Agreement with Deutsche Bank AG, London Branch, Merrill Lynch International, Citigroup Global Markets Limited and

J.P. Morgan Securities plc, as representatives of the several underwriters named therein (the “Underwriting Agreement”), relating

to the sale of €500,000,000 aggregate principal amount of the Company’s 3.500% Notes due 2028, €500,000,000 aggregate

principal amount of the Company’s 3.900% Notes due 2031 and €500,000,000 aggregate principal amount of the Company’s

4.100% Notes due 2034 (collectively, the “Notes”). The closing of the offering of Notes occurred on September 10, 2026.

The Notes were offered pursuant to the Company’s Registration

Statement on Form S-3 (file no. 333-293169), filed with the Securities and Exchange Commission (the “SEC”) on February 3,

2026, including the prospectus contained therein, a related preliminary prospectus supplement dated September 3, 2026 and a final

prospectus supplement dated September 3, 2026 (collectively, the “Registration Statement”). The Notes were issued pursuant

to an indenture dated as of November 17, 2000 (the “Base Indenture”), as supplemented by the First Supplemental Indenture

dated as of July 29, 2011 (the “First Supplemental Indenture”) and the Second Supplemental Indenture dated February 3,

2026 (the “Second Supplemental Indenture”, and together with the First Supplemental Indenture and the Base Indenture, the

“Indenture”), among the Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee.

The Company intends to use the net proceeds from the sale of the Notes

for general corporate purposes, which may include the repayment, redemption or refinancing of indebtedness.

The foregoing summary of the Underwriting Agreement does not purport

to be complete and is qualified in its entirety by reference to the text of the Underwriting Agreement, which is filed as Exhibit 1.1

hereto and incorporated by reference into this Item 8.01. The foregoing description of the Notes does not purport to be complete and is

qualified in its entirety by reference to the text of the Form of Global Note for the Company’s 3.500% Notes due 2028, Form of

Global Note for the Company’s 3.900% Notes due 2031 and Form of Global Note for the Company’s 4.100% Notes due 2034,

which are filed as Exhibit 4.1, Exhibit 4.2 and Exhibit 4.3, respectively, and incorporated by reference into this Item

8.01.

A copy of the opinion of Freshfields US LLP, relating to the validity

of the Notes, is incorporated by reference into the Registration Statement and is filed as Exhibit 5.1 hereto.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit Number

Description

1.1

Underwriting Agreement, dated as of September 3, 2026, among the Company and the several underwriters named therein

4.1

Form of Global Note for the Company’s 3.500% Notes due 2028

4.2

Form of Global Note for the Company’s 3.900% Notes due 2031

4.3

Form of Global Note for the Company’s 4.100% Notes due 2034

5.1

Opinion of Freshfields US LLP

23.1

Consent of Freshfields US LLP (included in Exhibit 5.1)

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities

Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

3M COMPANY

By:

/s/ Kevin H. Rhodes

Kevin H. Rhodes

Executive Vice President, Chief Legal Affairs Officer and Secretary

Dated: September 10, 2026

EX-1.1 — EXHIBIT 1.1

EX-1.1

Filename: tm2624999d1_ex1-1.htm · Sequence: 2

Exhibit 1.1

Execution Version

3M COMPANY

€500,000,000 3.500% Notes due 2028

€500,000,000 3.900% Notes due 2031

€500,000,000 4.100% Notes due 2034

Underwriting Agreement

September 3, 2026

Deutsche Bank AG, London Branch

Merrill Lynch International

Citigroup Global Markets Limited

J.P. Morgan Securities plc

As representatives (the “Representatives”)

of the several Underwriters named in Schedule I hereto,

c/o Deutsche Bank AG, London Branch

21 Moorfields

London EC2Y 9DB

United Kingdom

c/o Merrill Lynch International

2 King Edward Street

London EC1A 1HQ

United Kingdom

c/o Citigroup Global Markets Limited

Citigroup Centre

Canada Square

Canary Wharf

London E14 5LB

United Kingdom

c/o J.P. Morgan Securities plc

25 Bank Street

Canary Wharf

London E14 5JP

United Kingdom

Ladies and Gentlemen:

3M Company, a Delaware corporation

(the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to

issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of €500,000,000 principal

amount of its 3.500% Notes due 2028 (the “2028 Notes”), an aggregate of €500,000,000 principal amount of its 3.900%

Notes due 2031 (the “2031 Notes”) and an aggregate of €500,000,000 principal amount of its 4.100% Notes due 2034 (the

“2034 Notes” and, together with the 2028 Notes and the 2031 Notes, the “Securities”).

The Securities will be issued

as separate series of securities under an indenture, dated as of November 17, 2000 (as amended by the First Supplemental Indenture,

dated July 29, 2011, the Second Supplemental Indenture, dated February 3, 2026 and as the same may be further amended from

time to time, the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee

(the “Trustee”). The Trustee shall act as transfer agent and registrar with respect to the Securities.

The Company, The Bank of

New York Mellon, London Branch and The Bank of New York Mellon Trust Company, N.A. will execute and deliver a Paying Agency Agreement,

to be dated as of the Time of Delivery (the “Paying Agent Agreement”), pursuant to which The Bank of New York Mellon, London

Branch will be appointed as paying agent (the “Paying Agent”).

Each series of the Securities

will be issued in the form of a permanent global security (the “Global Notes”) and will be issued in book-entry form and

registered and in the name of a common depositary or its nominee (which may be the Paying Agent) on behalf of Clearstream Banking S.A.

(“Clearstream”) and Euroclear Bank SA/NV, as operator of the Euroclear System (“Euroclear”). The Securities will

be issued in denominations of €100,000 and integral multiples of €1,000 in excess thereof.

1.            The

Company represents and warrants to, and agrees with, each of the Underwriters that:

(a)           (i) An

“automatic shelf registration statement,” as defined under Rule 405 of the rules and regulations under the Securities

Act of 1933, as amended (the “Act”), on Form S-3, including a base prospectus relating to the various securities of

the Company, including the Securities, has been filed with the Securities and Exchange Commission (the “Commission”) not

earlier than three years prior to the date hereof; such registration statement, and any post-effective amendment thereto, became effective

on filing pursuant to Rule 462(e) under the Act; and no stop order suspending the effectiveness of such registration statement,

any post-effective amendment thereto or any part thereof has been issued and no proceeding for that purpose has been initiated or, to

the best knowledge of the Company after due inquiry, threatened by the Commission, and no notice of objection of the Commission to the

use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act has been

received by the Company; the various parts of such registration statement and any post-effective amendment thereto, including all exhibits

thereto, any information in a form of prospectus or any prospectus supplement that is deemed or retroactively deemed to be a part of

such registration statement, as amended, pursuant to Rule 430B or Rule 430C under the Act (which information shall be considered

to be included in such registration statement, as amended, as of the time specified in Rule 430B or Rule 430C, as the case

may be) that has not been superseded or modified and the documents incorporated by reference therein at the time such part of such registration

statement became effective but excluding Form T-1, each as amended at the time such part of such registration statement became effective,

is hereinafter collectively called the “Registration Statement”;

(ii) the term “Base Prospectus”

shall mean the base prospectus relating to the various securities of the Company, including the Securities, included in the Registration

Statement, in the form in which it has most recently been filed, or transmitted for filing, with the Commission on or prior to the date

of this Agreement;

(iii) the term “Prospectus

Supplement” shall mean the Base Prospectus together with any prospectus supplement relating to the Securities filed with the Commission

pursuant to Rule 424(b) under the Act prior to the offer and acceptance of the Securities;

(iv) the term “Pricing Prospectus”

shall mean the Prospectus Supplement, as amended and supplemented immediately prior to the Applicable Time (as defined below), as filed

by Company with the Commission pursuant to Rule 424(b); and

(v) the term “Prospectus”

shall mean the final Prospectus Supplement relating to the Securities and filed by the Company with the Commission pursuant to Rule 424(b).

Any reference herein to any

prospectus, including the Prospectus, Pricing Prospectus, Prospectus Supplement or the Base Prospectus shall be deemed to refer to and

include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Act, as of the date of each such

prospectus, as applicable; any reference to any amendment or supplement to any prospectus shall be deemed to refer to and include any

documents filed after the date of such prospectus, as the case may be, under the rules and regulations under the Securities Exchange

Act of 1934, as amended (the “Exchange Act”), and incorporated therein by reference; and any reference to any amendment to

the Registration Statement shall be deemed to refer to and include any annual report of the Company filed pursuant to Section 13(a) or

15(d) of the Exchange Act that is incorporated by reference in the Registration Statement after the effective date of the Registration

Statement;

(b)          For

the purposes of this Agreement, (i) the “Applicable Time” is 4:25 p.m. London time on the date of this Agreement,

(ii) the “Disclosure Package” will be the Pricing Prospectus as amended or supplemented at the Applicable Time, together

with the final term sheet prepared and filed pursuant to Section 5(a) hereof and (iii) the Disclosure Package, as of the

Applicable Time, did not, and as of the Time of Delivery (as defined below) will not, include any untrue statement of a material fact

or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they

are made, not misleading; provided, however, that the representations and warranties in clause (iii) of this Section 1(b) shall

not apply to statements or omissions made in any Disclosure Package in reliance upon and in conformity with the Underwriter Information

(as defined below);

“issuer free writing prospectus” as defined in Rule 433 under the Act relating to the Securities (an “Issuer Free

Writing Prospectus”) does not conflict (within the meaning of Rule 433(c)) with the information contained in the Registration

Statement, the Pricing Prospectus, or the Prospectus; and each (i) such Issuer Free Writing Prospectus, as supplemented by and taken

together with the Disclosure Package, and (ii) each investor presentation listed on Schedule III hereto, as supplemented by and

taken together with the Disclosure Package, as of the Applicable Time, did not and as of the Time of Delivery will not, include any untrue

statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the

circumstances under which they were made, not misleading; provided, however, that this representation and warranty shall

not apply to statements or omissions made in an Issuer Free Writing Prospectus in reliance upon and in conformity with the Underwriter

Information;

(d)          The

documents incorporated by reference in the Prospectus and the Disclosure Package, when they became effective or were filed with the Commission,

as the case may be, conformed in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the rules and

regulations of the Commission thereunder, and none of such documents contained an untrue statement of a material fact or omitted to state

a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not

misleading; and any further documents so filed and incorporated by reference in the Prospectus and the Disclosure Package or any further

amendment or supplement thereto, when such documents become effective or are filed with the Commission, as the case may be, will conform

in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the rules and regulations of the

Commission thereunder and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order

to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however,

that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with the

Underwriter Information;

(e)          The

Registration Statement, the Prospectus, the Pricing Prospectus and the Prospectus Supplement conform, and any further amendments or supplements

thereto will conform, in all material respects to the requirements of the Act and the Trust Indenture Act of 1939, as amended (the “Trust

Indenture Act”), and the rules and regulations of the Commission thereunder, and do not and will not, as of the applicable

effective date, in the case of the Registration Statement, and as of its applicable filing date in the case of the Prospectus, the Pricing

Prospectus and the Prospectus Supplement, contain an untrue statement of a material fact or omit to state a material fact required to

be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;

provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance

upon and in conformity with the Underwriter Information;

(f)          The

financial statements, and the related notes thereto, included or incorporated by reference in the Prospectus and the Disclosure Package,

present fairly the consolidated financial position of the Company and its consolidated subsidiaries as of the dates indicated and the

results of their operations and the changes in their consolidated cash flows for the periods specified; and said financial statements

have been prepared in conformity with accounting principles generally accepted in the United States applied on a consistent basis; and

the interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the Prospectus

and the Disclosure Package fairly presents the information called for in all material respects and has been prepared in accordance with

the Commission’s rules and guidelines applicable thereto;

(g)          Neither

the Company nor any of its subsidiaries has sustained since the date of the latest audited financial statements included or incorporated

by reference in the Prospectus and the Disclosure Package any material loss or interference with its business from fire, explosion, flood

or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree that

have resulted or would result in a material adverse change in the general affairs, management, current or future condition, financial

or otherwise, or in the earnings, business prospects, stockholders’ equity or results of operations of the Company and its subsidiaries

considered as one enterprise (a “Material Adverse Effect”), otherwise than as set forth or contemplated in the Prospectus

and the Disclosure Package; and, since the respective dates as of which information is given in the Registration Statement, the Prospectus

and the Disclosure Package, there has not been any change in the capital stock or long-term debt of the Company or any of its subsidiaries

or any material adverse change, or any development involving a prospective material adverse change, in or affecting the general affairs,

management, financial position, stockholders' equity or results of operations of the Company and its subsidiaries considered as one enterprise,

otherwise than as set forth or contemplated in the Prospectus and the Disclosure Package;

(h)          The

Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its

incorporation, with power and authority (corporate and other) to own its properties and conduct its business as described in the Prospectus

and the Disclosure Package and has been duly qualified as a foreign corporation for the transaction of business and is in good standing

under the laws of each other jurisdiction in which it owns or leases properties, or conducts any business, so as to require such qualification,

except where the failure to so qualify or be in good standing would not result in a Material Adverse Effect; and each subsidiary of the

Company with annual revenues (excluding inter-company activity) exceeding $400 million for the preceding fiscal year (the “Revenue

Target”) and each other subsidiary of the Company, if any, that is a significant subsidiary (as such term is defined in Rule 1-02

of Regulation S-X promulgated under the Act) (each, a “Significant Subsidiary”) of the Company has been duly incorporated

and is validly existing as a corporation in good standing under the law of its jurisdiction of incorporation and has been duly qualified

as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it

owns or leases properties, or conducts any business, so as to require such qualifications, except where the failure to so qualify or

be in good standing would not result in a Material Adverse Effect; the only subsidiaries of the Company which meet the Revenue Target

are 3M Japan Ltd, 3M International Trading (Shanghai) Co., Ltd., 3M Korea Co LTD, 3M Deutschland GMBH, 3M Canada Company, 3M do

Brasil Limitada, 3M Mexico, 3M China Limited, 3M India Limited, 3M Taiwan Limited, 3M Specialty Materials (Shanghai) Co., Ltd. and

3M United Kingdom PLC;

(i)           The

Company has an authorized capitalization as set forth in the Prospectus and the Disclosure Package and all of the issued shares of capital

stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable; and all of the issued shares

of capital stock of each Significant Subsidiary of the Company owned directly or indirectly by the Company have been duly and validly

authorized and issued, are fully paid and non-assessable and are owned free and clear of all liens, encumbrances, equities or claims,

except, with respect to joint venture subsidiaries, for such liens, encumbrances, equities or liens which do not individually or in the

aggregate have a Material Adverse Effect;

(j)           This

Agreement has been duly authorized, executed and delivered by the Company;

(k)          The

Paying Agent Agreement has been duly authorized by the Company and, when duly executed and delivered by each of the parties thereto,

will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, subject,

as to enforcement, to bankruptcy, insolvency, reorganization and other laws of general applicability relating to or affecting creditors'

rights and to general equity principles (the "Enforceability Exceptions");

(l)           The

Securities have been duly authorized, and, when issued and delivered pursuant to this Agreement, will have been duly executed, authenticated,

issued and delivered and will constitute valid and legally binding obligations of the Company entitled to the benefits provided by the

Indenture, which is substantially in the form filed as an exhibit to the Registration Statement; the Indenture has been duly authorized,

executed and delivered, and qualified under the Trust Indenture Act, and constitutes a valid and legally binding instrument, both the

Securities and the Indenture being enforceable in accordance with their respective terms, subject to the Enforceability Exceptions; and

the Indenture conforms and the Securities will conform to the descriptions thereof in the Prospectus and the Disclosure Package;

(m)          The

issue and sale of the Securities by the Company, the compliance by the Company with all of the provisions of the Securities, the Indenture

and this Agreement and the consummation of the transactions herein and therein contemplated will not conflict with or result in a breach

of any of the terms or provisions of, or constitute a default under, any material indenture, mortgage, deed of trust, loan agreement

or other agreement or instrument to which the Company is a party or by which the Company is bound or to which any of the property or

assets of the Company is subject, nor will such action result in any violation of the provisions of the Certificate of Incorporation,

as amended, or the By-Laws of the Company or any statute or any order, rule or regulation of any court or governmental agency or

body having jurisdiction over the Company or any of its properties; and no consent, approval, authorization, order, registration or qualification

of or with any court or governmental agency or body is required for the issue and sale of the Securities or the consummation by the Company

of the other transactions contemplated by this Agreement or the Indenture, except (i) such as have been obtained under the Act or

the Trust Indenture Act, (ii) such consents, approvals, authorizations, registrations or qualifications as may be required under

state securities or Blue Sky laws in connection with the purchase and distribution of the Securities by the Underwriters and (iii) any

such approvals under the applicable rules and regulations of the New York Stock Exchange (the “NYSE”) as may be required

to list the Securities on the NYSE;

(n)          Other

than as set forth or contemplated in the Registration Statement, the Prospectus and the Disclosure Package, there are no legal or governmental

proceedings pending to which the Company or any of its subsidiaries is a party or to which any property of the Company or any of its

subsidiaries is subject, which, if determined adversely to the Company or any of its subsidiaries, would individually or in the aggregate

result in a Material Adverse Effect, and, to the best of the Company's knowledge, no such proceedings, which if determined adversely,

would individually or in the aggregate have such a Material Adverse Effect, are threatened or contemplated by governmental authorities

or threatened by others;

(o)          Neither

the Company nor any of its subsidiaries is (i) in violation of its Certificate of Incorporation (or Articles of Incorporation) or

By-laws or (ii) in default in the performance or observance of any material obligation, covenant or condition contained in any indenture,

mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it or any of its properties

may be bound, except for such defaults that would not result in a Material Adverse Effect;

(p)          The

statements set forth in the Prospectus and the Disclosure Package under the captions “Debt Securities” and “Description

of the Notes”, insofar as they purport to constitute a summary of the terms of the Securities, and under the caption “Certain

U.S. Federal Income Tax Considerations”, insofar as it purports to describe the provisions of the laws and documents referred to

therein, are accurate, complete and fair;

(q)          The

Company is not and, after giving effect to the offering and sale of the Securities and the application of the proceeds as contemplated

by the Disclosure Package, will not be an “investment company” or an entity “controlled” by an “investment

company”, as such terms are defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”);

(r)           PricewaterhouseCoopers

LLP, who have certified certain financial statements of the Company and its subsidiaries, are independent public accountants as required

by the Act and the rules and regulations of the Commission thereunder;

(s)           (i)

(A) At the time of filing the Registration Statement, (B) at the time of the most recent amendment thereto for the

purposes of complying with Section 10(a)(3) of the Act (whether such amendment was by post-effective amendment,

incorporated report filed pursuant to Section 13 or 15(d) of the Exchange Act or form of prospectus) and (C) at the

time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the

Act) made any offer relating to the Securities in reliance on the exemption of Rule 163 under the Act, the Company was a

“well-known seasoned issuer” as defined in Rule 405 under the Act; and (ii) at the earliest time after the

filing of the Registration Statement that the Company or another offering participant made a bona fide offer (within the meaning of

Rule 164(h)(2) under the Act) of the Securities, the Company was not an “ineligible issuer” as defined in

Rule 405 under the Act;

(t)           The

Company maintains a system of internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the

Exchange Act) that complies with the requirements of the Exchange Act and has been designed by the Company's principal executive officer

and principal financial officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial reporting

and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Except

as disclosed in the Prospectus and the Disclosure Package, the Company's internal control over financial reporting is effective and the

Company is not aware of any material weaknesses in its internal control over financial reporting;

(u)          Except

as disclosed in the Prospectus and the Disclosure Package, since the date of the latest audited financial statements incorporated by

reference in the Prospectus and the Disclosure Package, there has been no change in the Company’s internal control over financial

reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial

reporting;

(v)          The

Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) that

comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material

information relating to the Company and its subsidiaries is made known to the Company’s principal executive officer and principal

financial officer by others within those entities; and such disclosure controls and procedures are effective;

(w)         Any

offer that is a written communication relating to the Securities made prior to the filing of the Registration Statement by the Company

or any person acting on its behalf (within the meaning, for this paragraph only, of Rule 163(c) under the Act) has been filed

with the Commission in accordance with the exemption provided by Rule 163 and otherwise complied with the requirements of Rule 163,

including, without limitation, the legending requirement, to qualify such offer for the exemption from Section 5(c) of the

Act provided by Rule 163;

(x)           The

Registration Statement is not the subject of a pending proceeding or examination under Section 8(d) or 8(e) of the Act,

and the Company is not the subject of a pending proceeding under Section 8A of the Act in connection with the offering of the Securities;

(y)          No

stamp, issuance, transfer or other similar taxes or duties are payable by or on behalf of the Underwriters under the current laws and

regulations of the United States or any political subdivision or any authority or agency therein or thereof having power to tax, or of

any other jurisdiction in which the Company is organized or is otherwise resident for tax purposes or any jurisdiction from or through

which a payment is made, in each case, on (i) the creation, issue or delivery by the Company of the Securities, (ii) the purchase

by the Underwriters of the Securities in the manner contemplated by this Agreement, or (iii) the execution and delivery of this

Agreement and the other transaction documents and the consummation of the transactions contemplated hereby and thereby;

(z)           The

Company has implemented and maintains in effect policies and procedures reasonably designed to ensure compliance by the Company, its

Subsidiaries, which, for purposes of this Section 1(z) means any entity of which the Company owns (either directly or indirectly)

a majority of the outstanding equity securities or other ownership interests carrying a majority of the voting power in the election

of the board of directors or other governing body of such entity (each such entity, a “Subsidiary”), and their respective

directors, officers, employees and agents in all material respects with (i) all laws, rules, and regulations of any jurisdiction

applicable to the Company or its Subsidiaries from time to time concerning or relating to bribery or corruption (the “Anti-Corruption

Laws”) and (ii) the applicable economic or financial sanctions or trade embargoes imposed, administered or enforced from time

to time by (a) the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department

of the Treasury or the U.S. Department of State, or (b) the United Nations Security Council, the European Union (the “EU”)

or His Majesty’s Treasury of the United Kingdom (collectively, “Sanctions”). The Company, its Subsidiaries, and to

the knowledge of the Company, its officers, employees, directors and agents when acting on behalf of the Company and its Subsidiaries,

are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. Neither the Company nor any of its Subsidiaries

is (a) a Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of

the U.S. Department of the Treasury, the U.S. Department of State, or by the United Nations Security Council, the EU or any EU member

state, (b) a Person operating, organized or resident in Sudan, Syria or a country or territory which is itself the subject or target

of any Sanctions to the extent such Person is the subject of Sanctions (which are, as of the date hereof, Cuba, Iran, North Korea

and the so-called Donetsk People’s Republic, the so-called Luhansk People’s Republic, the Crimea region

of Ukraine and the non-government controlled areas of Zaporizhzhia and Kherson), or (c) any Person controlled

or more than 50 percent owned by any such Person or Persons. The use of proceeds from the transactions contemplated by this Agreement

will not constitute (i) a violation of the United States Foreign Corrupt Practices Act of 1977, (ii) a violation of the United

Kingdom Bribery Act of 2010, or (iii) a material violation of any other Anti-Corruption Laws or applicable Sanctions. For purposes

of this Section 1(z), “Person” means any individual, corporation, partnership, limited liability company, joint venture,

association, joint stock company, trust, unincorporated organization or other entity or government or any agency or political subdivision

thereof. It is acknowledged and agreed that the representation and warranty contained in this Section 1(z) of this Agreement

is only sought and given to the extent that to do so would be permissible pursuant to (i) Council Regulation EC No. 2271/96,

as amended (the “Blocking Regulation”), (ii) any law or regulation implementing the Blocking Regulation in any member

state of the European Union, (iii) Council Regulation EC No. 2271/96 as it forms part of domestic law of the United Kingdom,

or (iv) with regard to Deutsche Bank AG, London Branch, Section 7 of the German Foreign Trade Ordinance (Verordnung zur Durchführung

des Außenwirtschaftsgesetzes (Außenwirtschaftsverordnung – AWV)); and

(aa)        The

Company and its subsidiaries’ information technology assets and equipment, computers, systems, networks, hardware, software, websites,

applications, and databases (collectively, “IT Systems”) operate and perform in all material respects in accordance with

their documentation and functional specifications in connection with their operation as used by the Company and its subsidiaries. The

Company has taken commercially reasonable steps to secure and protect the IT Systems from bugs, errors, defects, Trojan horses, time

bombs, malware and other corruptants that materially affect the use, functionality or performance of the IT Systems. The Company and

its subsidiaries have implemented and maintain commercially reasonable controls, policies, procedures, and safeguards to maintain and

protect their material confidential information and the integrity and security of critical IT Systems and data (including all personal,

personally identifiable, sensitive, confidential or regulated data (“Personal Data”)) used in connection with their businesses.

The Company has disaster recovery plans in the event of significant disruptions to critical IT Systems. To the Company’s knowledge,

there have been no unauthorized intrusion or breaches of security with respect to IT Systems that have had a Material Adverse Effect.

The Company and its subsidiaries are presently in compliance in all material respects with all applicable laws or statutes and all applicable

judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, if any, relating to

the protection and appropriate use of Personal Data. The Company and its subsidiaries have implemented reasonable internal policies and

contractual obligations, where appropriate, relating to the protection and appropriate use of Personal Data.

2.            Subject

to the terms and conditions herein set forth, the Company agrees to issue and sell to each of the Underwriters, and each of the Underwriters

agrees, severally and not jointly, to purchase from the Company, at a purchase price of 99.666% of the principal amount of the 2028 Notes,

99.567% of the principal amount of the 2031 Notes and 98.929% of the principal amount of the 2034 Notes, the principal amount of Securities

set forth opposite the name of such Underwriter in Schedule I hereto.

3.            Upon

the authorization by you of the release of the Securities, the several Underwriters propose to offer the Securities for sale upon the

terms and conditions set forth in the Pricing Prospectus and the Prospectus.

4.            (a)

Subject to the paragraph below, payment for the Securities shall be made by wire transfer, denominated in euros, of immediately available

funds to the account specified by the Company (such amount to be specified at least forty-eight hours in advance of the Time of Delivery).

The time and date of such delivery and payment shall be 9:30 a.m., London time, on September 10, 2026 or such other time and date

as the Representatives and the Company may agree upon in writing. Such time and date are herein called the “Time of Delivery”.

Deutsche Bank AG, London

Branch or such other Representative as the Representatives may agree to settle the Securities (the “Settlement Bank”) acknowledges

that the Securities represented by the Global Notes will initially be credited to an account (the “Commissionaire Account”)

for the benefit of the Settlement Bank the terms of which include a third-party beneficiary clause (‘stipulation pour autrui’)

with the Company as the third-party beneficiary and provide that such Securities are to be delivered to others only against payment of

the net subscription monies for the Securities ((i.e. less the commissions to be deducted from the subscription monies) with any transfer

taxes payable in connection with the sale of the Securities duly paid, without duplication, by the Company) into the Commissionaire Account

on a delivery against payment basis. The Settlement Bank acknowledges that (i) the Securities represented by the Global Notes shall

be held to the order of the Company as set out above and (ii) the net subscription monies for the Securities received in the Commissionaire

Account (i.e. less the commissions deducted from the subscription monies) will be held on behalf of the Company until such time as they

are transferred to the Company’s order. The Settlement Bank undertakes that the net subscription monies for the Securities (i.e.

less the commissions deducted from the subscription monies) will be transferred to the Company’s order promptly following receipt

of such monies in the Commissionaire Account. The Company acknowledges and accepts the benefit of the third-party beneficiary clause

(‘stipulation pour autrui’) pursuant to the Belgium and/or Luxembourg Civil Code, as applicable, in respect of the

Commissionaire Account.

Payment for the Securities

shall be made against delivery to you on the Time of Delivery for the respective accounts of the several Underwriters of the Securities

registered in such names and in such denominations as you shall request in writing not later than one full business day prior to the

Time of Delivery, with any transfer taxes payable in connection with the transfer of the Securities to the Underwriters duly paid.

(b)          The

documents to be delivered at the Time of Delivery by or on behalf of the parties hereto pursuant to Section 8 hereof, including

the cross-receipt for the Securities and any additional documents requested by the Underwriters pursuant to Section 8(j) hereof,

will be delivered to the Underwriters at the offices of Sidley Austin llp, 787 Seventh

Avenue, New York, New York 10019 (the “Closing Location”), and the Securities will be delivered at the Designated Office,

all at the Time of Delivery. A meeting will be held at the Closing Location at 10:00 a.m., London time, on the London Business Day next

preceding the Time of Delivery, at which meeting the final drafts of the documents to be delivered pursuant to the preceding sentence

will be available for review by the parties hereto. For the purposes of this Section 4, “London Business Day” shall

mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in London are generally authorized

or obligated by law or executive order to close.

5.            The

Company covenants and agrees with each of the Underwriters:

(a)           (i)

To prepare the Prospectus in a form approved by you and to file such Prospectus pursuant to Rule 424(b) under the Act not

later than the Commission's close of business on the second business day following the date of this Agreement; to make no further

amendment or any supplement to the Registration Statement, the Prospectus or the Pricing Prospectus prior to the Time of Delivery

which shall be reasonably disapproved by you promptly after reasonable notice thereof; (ii) to prepare a final term sheet,

containing solely a description of the Securities, in a form approved by you and to file such term sheet pursuant to

Rule 433(d) under the Act within the time required by such Rule; (iii) to file promptly all reports and any

definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a),

13(c), 14 or 15(d) of the Exchange Act and for so long as delivery of a prospectus is required (or but for the exemption in

Rule 172 would be required) in connection with the offering or sale of the Securities, and during such time period to advise

you, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or has

become effective or any supplement to the Prospectus or the Pricing Prospectus or any amended Prospectus or Pricing Prospectus has

been filed with the Commission, of the issuance by the Commission of any stop order or of any order preventing or suspending the use

of any prospectus relating to the Securities or of any notice of objection to the use of the Registration Statement or any

post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act relating to the Securities; (iv) the

Company becoming the subject of a proceeding under Section 8A of the Act in connection with the offering of the Securities and

of, the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the initiation or threatening

of any proceeding for any such purpose, or of any request by the Commission for the amendment or supplement of the Registration

Statement, the Prospectus or the Pricing Prospectus or for additional information; and (v) in the event of the issuance of any

such stop order or of any such order preventing or suspending the use of any such prospectus or suspending any such qualification or

any such notice of objection, to use promptly its best efforts to obtain its withdrawal;

(b)          Promptly

from time to time to take such action as you may reasonably request to qualify the Securities for offering and sale under the securities

laws of such jurisdictions as you may request and to comply with such laws so as to permit the continuance of sales and dealings therein

for as long as may be necessary to complete the distribution or sale of the Securities; provided, however, that in connection

therewith the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in

any jurisdiction;

furnish you with copies of the Registration Statement and each amendment thereto, with copies of the Prospectus or the Pricing Prospectus

as each time amended or supplemented in the form in which it is filed with the Commission pursuant to Rule 424 under the Act, and

with copies of the documents incorporated by reference therein, all in such quantities as you may reasonably request from time to time;

and, if the delivery of a prospectus is (or but for the exemption in Rule 172 would be) required at any time in connection with

the offering or sale of the Securities and if at such time any event shall have occurred as a result of which the Prospectus or the Pricing

Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary

in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus or Pricing

Prospectus is delivered (or but for the exemption in Rule 172 would be delivered) not misleading, or, if for any other reason it

shall be necessary during such same period to amend or supplement the Prospectus or the Pricing Prospectus or to file under the Exchange

Act any document incorporated by reference in the Prospectus or the Pricing Prospectus in order to comply with the Act, the Exchange

Act or the Trust Indenture Act, to notify you and upon your request to file such document and to prepare and furnish without charge to

each Underwriter and to any dealer in securities as many written and electronic copies as you may from time to time reasonably request

of an amended Prospectus or Pricing Prospectus or a supplement to the Prospectus or the Pricing Prospectus which will correct such statement

or omission or effect such compliance;

(d)          To

make generally available to its security holders as soon as practicable, but in any event not later than eighteen months after the effective

date of the Registration Statement (as defined in Rule 158(c) under the Act), an earnings statement of the Company and its

subsidiaries (which need not be audited) complying with Section 11(a) of the Act and the rules and regulations of the

Commission thereunder (including, at the option of the Company, Rule 158) by making an appropriate filing with the Commission if

the Company is subject to the reporting requirements of the Exchange Act or by other means if the Company is not so subject;

(e)          That,

from the date of this Agreement and continuing to and including the later of the Time of Delivery and such earlier time as you may notify

the Company, the Company will not, without your prior written consent offer, sell, contract to sell or otherwise dispose of any debt

securities of the Company (other than the sale of Securities pursuant to this Agreement) issued or guaranteed by the Company and having

a tenor of more than one year;

(f)           To

pay the required Commission filing fees relating to the Securities within the time required by Rule 456(b)(1)(i) under the

Act without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the Act (including,

if applicable, by updating the “Calculation of Registration Fee” table in accordance with Rule 456(b)(1)(ii) either

in a post-effective amendment to the Registration Statement or in the manner specified by Rule 424(g) in the Prospectus filed

pursuant to Rule 424(b));

(g)          If

by the third anniversary (the “Renewal Deadline”) of the initial effective date of the Registration Statement any of the

Securities remain unsold by the Underwriters, the Company will file, if it has not already done so and is eligible to do so, a new automatic

shelf registration statement relating to the Securities, in a form satisfactory to you. If, at the Renewal Deadline, the Company is no

longer eligible to file an automatic shelf registration statement, the Company will, if it has not already done so, file a new shelf

registration statement relating to the Securities, in a form satisfactory to you and will use its best efforts to cause such registration

statement to be declared effective within 90 days after the Renewal Deadline. The Company will take all other action necessary or

appropriate to permit the public offering and sale of the Securities to continue as contemplated in the expired registration statement

relating to the Securities. References herein to the Registration Statement shall include such new automatic shelf registration statement

or such new shelf registration statement, as the case may be;

(h)          The

Company will use its commercially reasonable efforts to effect the admission, listing and trading of the Securities on the NYSE as promptly

as practicable and, upon such listing, will use its commercially reasonable efforts to maintain such listing and satisfy the requirements

for such continued listing;

(i)           To

pay any stamp duty or other issue, transaction, value added or similar tax or duty (including court fees) payable in the United States

of America, Belgium, Luxembourg or the United Kingdom in connection with the issue and distribution of the Securities or the enforcement

or delivery of this Agreement;

(j)            If

required by Rule 430B(h) under the Act, to prepare a form of prospectus in a form approved by you and to file such form of

prospectus pursuant to Rule 424(b) under the Act not later than may be required by Rule 424(b) under the Act; and

to make no further amendment or supplement to such form of prospectus which shall be disapproved by you promptly after reasonable notice

thereof;

(k)          To

use the net proceeds received by it from the sale of the Securities pursuant to this Agreement in the manner specified in the Pricing

Prospectus and the Prospectus under the caption “Use of Proceeds”; and

(l)           The

Company will cooperate with the Underwriters and the Paying Agent in arranging for the Securities to be eligible for clearance and settlement

through Euroclear and Clearstream.

(a)          (i)          The

Company represents and agrees that, other than the final term sheet prepared and filed pursuant to Section 5(a) hereof, unless

it obtains the prior consent of the Representatives, it has not made and will not make any offer relating to the Securities that would

constitute a “free writing prospectus,” as defined in Rule 405 under the Act, required to be filed with the Commission;

(ii)       each

Underwriter represents and agrees that, without the prior consent of the Company and the Representatives, other than one or more term

sheets relating to the Securities containing customary information and conveyed to purchasers of Securities, it has not made and will

not make any offer relating to the Securities that would constitute a free writing prospectus required to be filed with the Commission;

and

(iii)      any

such free writing prospectus the use of which has been consented to by the Company and the Representatives (including the final term

sheet prepared and filed pursuant to Section 5(a) hereof) is listed on Schedule II hereof;

(b)          The

Company has complied and will comply with the requirements of Rule 433 under the Act applicable to any Issuer Free Writing Prospectus,

including timely filing with the Commission where required, legending and recordkeeping; and

Company agrees that if at any time following issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of

which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the Pricing Prospectus or

the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make

the statements therein, in the light of the circumstances then prevailing, not misleading, the Company will give prompt notice thereof

to the Representatives and, if requested by the Representatives, will prepare and furnish without charge to each Underwriter an Issuer

Free Writing Prospectus or other document which will correct such conflict, statement or omission; provided, however, that

this representation and warranty shall not apply to any statements or omissions in an Issuer Free Writing Prospectus made in reliance

upon and in conformity with the Underwriter Information.

7.            The

Company covenants and agrees with the several Underwriters that the Company will pay or cause to be paid the following: (i) the

fees and expenses of the Company's counsel and accountants in connection with the registration of the Securities under the Act and all

other expenses in connection with the preparation, printing and filing of the Registration Statement, any Prospectus Supplement, the

Base Prospectus, any Issuer Free Writing Prospectus and the Prospectus and amendments and supplements thereto and the mailing and delivering

of copies thereof to the Underwriters and dealers; (ii) the cost of printing, preparing by word processor or reproducing this Agreement,

any Indenture, any Blue Sky Memoranda and any other documents in connection with the offering, purchase, sale and delivery of the Securities;

(iii) all expenses in connection with the qualification of the Securities for offering and sale under state securities laws as provided

in Section 5(b) hereof, including fees and disbursements of counsel for the Underwriters in connection with such qualification

and in connection with the Blue Sky and legal investment surveys; (iv) any fees charged by securities rating services for rating

the Securities; (v) any filing fees incident to any required review by the Financial Industry Regulatory Authority, Inc. of

the terms of the sale of the Securities; (vi) the cost of preparing the Securities; (vii) the fees and expenses of the Trustee

and any agent of the Trustee and the fees and disbursements of counsel for the Trustee in connection with the Indenture and the Securities;

(viii) any advertising connected with the sale of Securities so long as such advertising expenses have been approved by the Company;

(ix) the approval of the Securities for book-entry transfer through the facilities of Clearstream and Euroclear; (x) the fees

and expenses incurred in connection with the listing of the Securities on the NYSE and admission to trading on the NYSE; and (xi) all

other costs and expenses incident to the performance of the Company’s obligations hereunder which are not otherwise specifically

provided for in this Section. Except as provided in this Section, and Sections 9 and 12 hereof, each Underwriter shall pay all other

expenses it incurs. Except as otherwise stated in this Section 7, the Underwriters shall pay the fees and disbursements of their

counsel, and the Company shall have no liability for such fees and disbursements.

8.            The

obligations of the Underwriters hereunder shall be subject, in their discretion, to the condition that all representations and warranties

and other statements of the Company herein are, at and as of the Applicable Time and the Time of Delivery, true and correct, the condition

that the Company shall have performed all of its obligations hereunder theretofore to be performed, and the following additional conditions:

(a)          The

Prospectus shall have been filed with the Commission pursuant to Rule 424(b) under the Act within the applicable time period

prescribed for such filing by the rules and regulations under the Act and in accordance with Section 5(a) hereof; the

final term sheet contemplated by Section 5(a) hereof, and any other material required to be filed by the Company pursuant to

Rule 433(d) under the Act, shall have been filed with the Commission within the applicable time periods prescribed for such

filings by Rule 433; no stop order suspending the effectiveness of the Registration Statement, or the use of the Prospectus Supplement

or the Prospectus, shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission

nor shall any order preventing or suspending the use of any prospectus relating to the Securities or any notice of objection to the use

of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act relating to

the Securities have been issued; and all requests for additional information on the part of the Commission shall have been complied with

to your reasonable satisfaction;

(b)          Sidley

Austin llp, counsel to the Underwriters, shall have furnished to you such written opinion

or opinions, dated the Time of Delivery, with respect to the incorporation of the Company, the validity of the Indenture, the Securities,

the Registration Statement and the Prospectus and other related matters as you may reasonably request, and such counsel shall have received

such papers and information as they may reasonably request to enable them to pass upon such matters;

US LLP, counsel to the Company, shall have furnished to you such counsel’s written opinions, dated the Time of Delivery, in form

and substance satisfactory to you, and Thomas Osteraas, Associate General Counsel of the Company, shall have furnished to you such counsel’s

written opinions, dated the Time of Delivery, in form and substance satisfactory to you;

(d)          On

the date of this Agreement and at the Time of Delivery, the independent registered public accounting firm that has certified the financial

statements of the Company and its subsidiaries included or incorporated by reference in the Registration Statement shall have furnished

to you a letter or letters, dated the respective dates of delivery thereof, in form and substance satisfactory to you;

(e)          The

Securities shall be eligible for clearance and settlement through the facilities of Clearstream and Euroclear;

(f)           The

Company shall have made or caused to be made an application for the Securities to be admitted to listing and trading on the NYSE;

(g)          The

Paying Agent Agreement shall have been duly executed and delivered by a duly authorized officer of the Company, the Paying Agent and

the Trustee;

(h)          (i)          Neither

the Company nor any of its subsidiaries shall have sustained since the date of the latest audited financial statements included or incorporated

by reference in the Disclosure Package and the Prospectus any loss or interference with its business from fire, explosion, flood or other

calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree that would

result in a Material Adverse Effect, otherwise than as set forth or contemplated in the Disclosure Package and the Prospectus, and (ii) since

the respective dates as of which information is given in the Disclosure Package and the Prospectus there shall not have been any change

in the capital stock or long-term debt of the Company or any of its subsidiaries or any change, or any development involving a prospective

change, in or affecting the general affairs, management, financial position, stockholders' equity or results of operations of the Company

and its subsidiaries considered as one enterprise, otherwise than as set forth or contemplated in the Disclosure Package and the Prospectus,

the effect of which, in any such case described in clause (i) or (ii), is in your judgment so material and adverse as to make it

impracticable or inadvisable to proceed with the public offering or the delivery of the Securities on the terms and in the manner contemplated

in the Disclosure Package and the Prospectus;

(i)           On

or after the Applicable Time there shall not have occurred any of the following: (i) a suspension or material limitation in trading

in securities generally on the NYSE or the NASDAQ Global Market; (ii) a suspension or material limitation in trading in the Company’s

securities on the NYSE; (iii) a general moratorium on commercial banking activities in New York declared by either Federal or New

York State authorities; (iv) a material adverse change in the financial markets of the United States, any material interruption

in the clearance and settlement systems in the United States or an outbreak or escalation of hostilities or the declaration of a national

emergency or war if the effect of any such event specified in this clause (iv) in your judgment makes it impracticable or inadvisable

to proceed with the public offering or the delivery of the Securities on the terms and in the manner contemplated in the Disclosure Package

and the Prospectus; (v) any downgrading in the rating accorded the Company’s debt securities by any “nationally recognized

statistical rating organization”, as that term is defined in Section 3(a)(62) of the Exchange Act; or (vi) any such organization

shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the

Company’s debt securities; and

(j)          The

Company shall have furnished or caused to be furnished to you at the Time of Delivery certificates of officers of the Company, in such

form and executed by such officers of the Company as shall be satisfactory to you, as to the accuracy of the representations and warranties

of the Company herein at and as of such time, as to the performance by the Company of all of its obligations hereunder to be performed

at or prior to such time, as to the matters set forth in subsections (a) and (i) of this Section 8 and as to such other

matters as you may reasonably request.

9.          (a)          The

Company will indemnify and hold harmless each Underwriter against any losses, claims, damages or liabilities, joint or several, to which

such Underwriter may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in

respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration

Statement, any preliminary prospectus, the Pricing Prospectus, the Prospectus, any Issuer Free Writing Prospectus, any “issuer

information” filed or required to be filed under Rule 433(d) under the Act, any amendment or supplement thereto, or any

investor presentation listed on Schedule III hereto, or arise out of or are based upon the omission or alleged omission to state therein

a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse each Underwriter

for any legal or other expenses reasonably incurred, as incurred, by such Underwriter in connection with investigating or defending any

such action or claim; provided, however, that the Company shall not be liable in any such case to the extent that any such

loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged

omission made in the Registration Statement, any preliminary prospectus, the Pricing Prospectus, the Prospectus or the Prospectus as

amended or supplemented, or any Issuer Free Writing Prospectus, or any such amendment or supplement, in reliance upon and in conformity

with the Underwriter Information.

(b)          Each

Underwriter severally and not jointly will indemnify and hold harmless the Company against any losses, claims, damages or liabilities

to which the Company may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions

in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the

Registration Statement, any preliminary prospectus, the Pricing Prospectus, the Prospectus, or any Issuer Free Writing Prospectus, or

arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary

to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged

untrue statement or omission or alleged omission was made in the Registration Statement, any preliminary prospectus, the Pricing Prospectus,

the Prospectus or any Issuer Free Writing Prospectus, or any such amendment or supplement, in reliance upon and in conformity with the

Underwriter Information; and will reimburse the Company for any legal or other expenses reasonably incurred, as incurred, by the Company

in connection with investigating or defending any such action or claim. As used in this Agreement with respect to an Underwriter and

an applicable document, “Underwriter Information” shall mean the written information furnished to the Company by such Underwriter

through the Representatives expressly for use therein; it being understood and agreed upon that the only such information furnished by

any Underwriter consists of the following information in the Prospectus furnished on behalf of each Underwriter: the sixth and seventh

sentences of the seventh paragraph, the tenth paragraph and the eleventh paragraph under the caption “Underwriting”.

after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified

party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying

party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve it from any liability

which it may have to any indemnified party otherwise than under such subsection. In case any such action shall be brought against any

indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to

participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the

defense thereof, with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party,

be counsel to the indemnifying party), and, after notice from the indemnifying party to such indemnified party of its election so to

assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal

expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the

defense thereof other than reasonable costs of investigation. An indemnifying party shall not be liable for any settlement of any proceeding

effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying

party agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. No indemnifying

party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of

any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought

hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise

or judgment (i) includes an unconditional release of the indemnified party from all liability arising out of such action or claim

and (ii) does not include a statement as to, or an admission of, fault, culpability or a failure to act, by or on behalf of any

indemnified party.

(d)          If

the indemnification provided for in this Section 9 is unavailable to or insufficient to hold harmless an indemnified party under

subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred

to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such

losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits

received by the Company on the one hand and the Underwriters on the other from the offering of the Securities to which such loss, claim,

damage or liability (or action in respect thereof) relates. If, however, the allocation provided by the immediately preceding sentence

is not permitted by applicable law or if the indemnified party failed to give the notice required under subsection (c) above, then

each indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate

to reflect not only such relative benefits but also the relative fault of the Company on the one hand and the Underwriters on the other

in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof),

as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters

on the other shall be deemed to be in the same proportion as the total net proceeds from the sale of Securities (before deducting expenses)

received by the Company bear to the total commissions or discounts received by the Underwriters, in each case as set forth in the table

on the cover page of the Prospectus. The relative fault shall be determined by reference to, among other things, whether the untrue

or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact required to be stated therein

or necessary in order to make the statements therein not misleading, relates to information supplied by the Company on the one hand or

the Underwriters on the other and the parties' relative intent, knowledge, access to information and opportunity to correct or prevent

such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to

this subsection (d) were determined by per capita allocation (even if the Underwriters were treated as one entity for such purpose)

or by any other method of allocation which does not take account of the equitable considerations referred to above in this subsection

(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect

thereof) referred to above in this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by

such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this

subsection (d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total public offering

price at which the Securities purchased by it were sold exceeds the amount of any damages which such Underwriter has otherwise been required

to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation

(within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such

fraudulent misrepresentation. The Underwriters' obligations in this subsection (d) to contribute are several in proportion to their

respective underwriting obligations to which such loss, claim, damage or liability (or action in respect thereof) relates and are not

joint.

(e)          The

obligations of the Company under this Section 9 shall be in addition to any liability which the Company may otherwise have and shall

extend, upon the same terms and conditions, to each person, if any, who controls any Underwriter within the meaning of the Act; and the

obligations of the Underwriters under this Section 9 shall be in addition to any liability which the respective Underwriters may

otherwise have and shall extend, upon the same terms and conditions, to each officer and director of the Company and to each person,

if any, who controls the Company within the meaning of the Act.

10.          (a)

If any Underwriter shall default in its obligation or, in accordance with the exercise of Bail-in Powers described in Section 24

hereof, is no longer obligated to purchase the Securities which it has agreed to purchase hereunder, you may in your discretion arrange

for you or another party or other parties to purchase such Securities on the terms contained herein. If within twenty-four hours after

such default by any Underwriter you do not arrange for the purchase of such Securities, then the Company shall be entitled to a further

period of thirty six hours within which to procure another party or other parties satisfactory to you to purchase such Securities on

such terms, or, pursuant to an exercise of Bail-in Powers described in Section 24 hereof, failure to purchase the Securities. In

the event that, within the respective prescribed periods, you notify the Company that you have so arranged for the purchase of such Securities,

or the Company notifies you that it has so arranged for the purchase of such Securities, you or the Company shall have the right to postpone

the Time of Delivery for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary in the

Registration Statement or the Prospectus, or in any other documents or arrangements, and the Company agrees to file promptly any amendments

or supplements to the Registration Statement or the Prospectus which in your opinion may thereby be made necessary. The term “Underwriter”

as used in this Agreement shall include any person substituted under this Section or in Section 24 with like effect as if such

person had originally been a party to this Agreement with respect to such Securities.

(b)          If,

after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter, or of an Underwriter no longer

obligated to purchase in accordance with the exercise of Bail-in Powers described in Section 24 hereof, by the remaining Underwriters

by you and the Company as provided in subsection (a) above, the aggregate principal amount of such Securities which remains unpurchased

does not exceed 10% of the aggregate principal amount of all the Securities, then the Company shall have the right to require each non-defaulting

Underwriter to purchase the principal amount of Securities which such Underwriter agreed to purchase hereunder and, in addition, to require

each non-defaulting Underwriter to purchase its pro rata share (based on the principal amount of Securities which such Underwriter agreed

to purchase hereunder) of the Securities of such defaulting Underwriter, or of an Underwriter no longer obligated to purchase in accordance

with the exercise of Bail-in Powers described in Section 24 hereof, for which such arrangements have not been made; but nothing

herein shall relieve a defaulting Underwriter, or of an Underwriter no longer obligated to purchase in accordance with the exercise of

Bail-in Powers described in Section 24 hereof, from liability for its default.

after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter, or of an Underwriter no longer

obligated to purchase in accordance with the exercise of Bail-in Powers described in Section 24 hereof, by the remaining Underwriters

by you and the Company as provided in subsection (a) above, the aggregate principal amount of Securities which remains unpurchased

exceeds 10% of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in subsection

(b) above to require non-defaulting Underwriters to purchase Securities of a defaulting Underwriter, or of an Underwriter no longer

obligated to purchase in accordance with the exercise of Bail-in Powers described in Section 24 hereof, by the remaining Underwriters,

then this Agreement shall thereupon terminate, without liability on the part of any non-defaulting Underwriter or the Company, except

for the expenses to be borne by the Company and the Underwriters as provided in Section 7 hereof and the indemnity and contribution

agreements in Section 9 hereof; but nothing herein shall relieve a defaulting Underwriter, or of an Underwriter no longer obligated

to purchase in accordance with the exercise of Bail-in Powers described in Section 24 hereof, from liability for its default.

11.          The

respective indemnities, agreements, representations, warranties, covenants and other statements of the several Underwriters and the Company,

as set forth in or made pursuant to this Agreement shall remain in full force and effect regardless of any investigation (or any statement

as to the results thereof) made by or on behalf of any Underwriter or any controlling person of any Underwriter, or the Company, or any

officer or director or any controlling person of the Company, and shall survive delivery of and payment for the Securities.

12.          If

this Agreement shall be terminated pursuant to Section 10 hereof or the issue and sale of the Securities is not consummated as a

result of the failure of any of the conditions set forth in clauses (i), (iii) or (iv) of Section 8(i), the Company shall

not then be under any liability to any Underwriter except as provided in Sections 7 and 9 hereof; but, if for any other reason, the Securities

are not delivered by or on behalf of the Company as provided herein, the Company will reimburse the Underwriters through you for all

out of pocket expenses approved in writing by you, including fees and disbursements of counsel, reasonably incurred by the Underwriters

in making preparations for the purchase, sale and delivery of the Securities, but the Company shall then be under no further liability

to any Underwriter except as provided in Sections 7 and 9 hereof.

13.          In

all dealings hereunder, you shall act on behalf of each of the Underwriters, and the parties hereto shall be entitled to act and rely

upon any statement, request, notice or agreement on behalf of any Underwriter made or given by you.

All statements, requests, notices and agreements

hereunder shall be in writing, and if to the Underwriters shall be delivered or sent by mail, telex or facsimile transmission to you

as the representatives and shall be sufficient in all respects when delivered or sent by facsimile transmission or registered mail to

Deutsche Bank AG, London Branch, 21 Moorfields, London EC2Y 9DB, United Kingdom, Telephone: +44 207 545 4361, Attention: DCM Debt Syndicate;

Merrill Lynch International, 2 King Edward Street, London EC1A 1HQ, United Kingdom, Tel: +44 (0)20 7995 3966, Email: dcm_london@bofa.com,

Attn: Syndicate Desk; Citigroup Global Markets Limited, Citigroup Centre, Canada Square, Canary Wharf, London E14 5LB, United Kingdom,

Fax No.: +44 20 7986 1927, Attention: Syndicate Desk and J.P. Morgan Securities plc, 25 Bank Street, Canary Wharf, London E14 5JP, United

Kingdom, Email: emea_syndicate@jpmorgan.com, Attention: Head of International Syndicate; and if to the Company shall be shall be sufficient

in all respects when delivered or sent by facsimile transmission or registered mail to 3M Legal Affairs, 3M Center, St. Paul, Minnesota

55144-1000, email: DealNotices@mmm.com, Attention: Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer &

Secretary; Any such statements, requests, notices or agreements shall take effect upon receipt thereof.

14.          The

Company acknowledges and agrees that (i) the purchase and sale of the Securities pursuant to this Agreement is an arm's-length commercial

transaction between the Company, on the one hand, and the several Underwriters, on the other, (ii) in connection therewith and with

the process leading to such transaction each Underwriter is acting solely as a principal and not the agent or fiduciary of the Company,

(iii) no Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated

hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other

matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement and (iv) the Company

has consulted its own legal and financial advisors to the extent it deemed appropriate. The Company agrees that it will not claim that

the Underwriters, or any of them, has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to the

Company, in connection with such transaction or the process leading thereto.

15.          This

Agreement shall be binding upon, and inure solely to the benefit of, the Underwriters, the Company, and to the extent provided in Sections

9 and 11 hereof, the officers and directors of the Company and any person who controls any Underwriter or the Company, and their respective

personal representatives, successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement.

No purchaser of any of the Securities from any Underwriter shall be deemed a successor or assign by reason merely of such purchase.

16.          In

accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters

are required to obtain, verify and record information that identifies their respective clients, including the Company, which information

may include the name and address of their respective clients, as well as information that will allow the Underwriters to properly identify

their respective clients.

17.          Time

shall be of the essence in this Agreement. As used herein, the term “business day” shall mean any day when the office of

the Commission in Washington, D.C. is normally open for business.

18.          THIS

AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

19.          The

parties hereby submit to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The

City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The

parties waive any objection which any of them may now or hereafter have to the laying of venue of any such suit or proceeding in such

courts. Each party agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding

upon such party and may be enforced in any court to the jurisdiction of which such party is subject by a suit upon such judgment.

20.          Each

of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement.

21.          This

Agreement may be executed by any one or more of the parties hereto in any number of counterparts (which may include counterparts delivered

by any standard form of telecommunication), each of which shall be deemed to be an original, but all of such respective counterparts

shall together constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic

signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act

or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have

been duly and validly delivered and be valid and effective for all purposes.

22.          The

Company agrees to indemnify each Underwriter against any loss incurred by such Underwriter as a result of any judgment or order being

given or made for any amount due hereunder and such judgment or order being expressed and paid in a currency (the “Judgment Currency”)

other than the euro and as a result of any variation as between (i) the rate of exchange at which the euro amount is converted into

the Judgment Currency for the purpose of such judgment or order and (ii) the rate of exchange at which such Underwriter is able

to purchase euros with the amount of the Judgment Currency actually received by such Underwriter. The foregoing indemnity shall constitute

a separate and independent obligation of the Company and shall continue in full force and effect notwithstanding any such judgment or

order as aforesaid. The term “rate of exchange” shall include any premiums and costs of exchange payable in connection with

the purchase of, or conversion into, the relevant currency.

23.          The

execution of this Agreement by all parties will constitute the Underwriters’ acceptance of the International Capital Market Association

Agreement Among Managers Version 1/New York Schedule (the “Agreement Among Managers”) subject to any amendment notified to

the Underwriters in writing at any time prior to the execution of this Agreement. References to the “Managers” shall be deemed

to refer to the Underwriters, references to the “Lead Manager” and the “Joint Bookrunners” shall be deemed to

refer to Deutsche Bank AG, London Branch, Merrill Lynch International, Citigroup Global Markets Limited and J.P. Morgan Securities plc,

and references to the “Settlement Lead Manager,” the “Stabilisation Manager” and the “Stabilisation Coordinator”

shall be deemed to refer to Deutsche Bank AG, London Branch. As applicable to the Representatives, Clause 3 of the Agreement Among Managers

shall be deemed to be deleted in its entirety and replaced with Section 10 of this Agreement. Notwithstanding anything contained

in the Agreement Among Managers, each Underwriter hereby agrees that the Settlement Lead Manager may allocate such Underwriter’s

pro rata share of expenses incurred by the Underwriters in connection with the offering of the Securities to the account of such Underwriter

for settlement of accounts (including payment of such Underwriter’s fees by the Settlement Lead Manager) as soon as practicable

but in any case no later than 90 days following the Time of Delivery. In addition, the Underwriters hereby agree, as between themselves

only, that, for the purposes of Clause 2 of the Agreement Among Managers, their respective underwriting commitments will be in the amounts

set out in Schedule I to this Agreement.

24.          Notwithstanding

and to the exclusion of any other term of this Agreement or any other agreements, arrangements, or understanding between any Underwriter

and the Company, the Company acknowledges and accepts that a BRRD Liability arising under this Agreement may be subject to the exercise

of Bail-in Powers by the Relevant Resolution Authority, and acknowledges, accepts, and agrees to be bound by:

(a)          the

effect of the exercise of Bail-in Powers by the Relevant Resolution Authority in relation to any BRRD Liability of an Underwriter to

the Company under this Agreement, that (without limitation) may include and result in any of the following, or some combination thereof:

i. the reduction of all, or a portion, of the

BRRD Liability or outstanding amounts due thereon;

ii. the conversion of all, or a portion, of

the BRRD Liability into shares, other securities or other obligations of such Underwriter

or another person, and the issue to or conferral on the Company of such shares, securities

or obligations;

iii. the cancellation of the BRRD Liability;

iv. the amendment or alteration of any interest,

if applicable, thereon, the maturity or the dates on which any payments are due, including

by suspending payment for a temporary period; and

(b)          the

variation of the terms of this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of

Bail-in Powers by the Relevant Resolution Authority.

“Bail-in Legislation”

means (a) in relation to a member state of the European Economic Area which has implemented, or which at any time implements, the

BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU Bail-in Legislation Schedule from time

to time and (b) in relation to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time)

and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment

firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).

“Bail-in Powers”

means (a) in relation to a member state of the European Economic Area which has implemented, or which at any time implements, the

BRRD, any Write-down and Conversion Powers as defined in the EU Bail-in Legislation Schedule, in relation to the relevant Bail-in Legislation

and (b) in relation to the United Kingdom, any powers of the Relevant Resolution Authority under the Bail-In Legislation to cancel,

transfer or dilute shares issued by a person that is a bank or investment fim or affiliate of a bank or investment firm to cancel, reduce,

modify or change the form of a liability of such a person or any contract or instrument under which that liability arises, to convert

all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract

or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability.

“BRRD” means

Directive 2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms.

“BRRD Liability”

means a liability in respect of which the relevant Write Down and Conversion Powers in the applicable Bail-in Legislation and/or Bail-In

Powers may be exercised.

“EU Bail-in Legislation

Schedule” means the document described as such, then in effect, and published by the Loan Market Association (or any successor

person) from time to time at http://www.lma.eu.com/pages.aspx?p=499.

“Relevant Resolution

Authority” means the resolution authority with the ability to exercise any Bail-in Powers in relation to the relevant Underwriter.

25.          The

Company hereby confirms the appointment of Deutsche Bank AG, London Branch in its role as stabilization manager (the “Stabilizing

Manager”) (or any person acting on behalf of the Stabilizing Manager) to over-allot Securities or effect transactions with a view

to supporting the market price of the Securities at a level higher than that which might otherwise prevail. In connection with the issue

of the Securities, the Stabilizing Manager (or any person acting on behalf of the Stabilizing Manager) may over-allot Securities or effect

transactions with a view to supporting the market price of the Securities at a level higher than that which might otherwise prevail.

However, stabilization may not necessarily occur. Any stabilization action may begin on or after the date on which adequate public disclosure

of the final terms of the offer of the Securities is made, and, if begun, may cease at any time, but it must end no later than the earlier

of 30 days after the issue of the Securities and 60 days after the date of the allotment of the Securities. Such stabilization shall

be carried out in accordance with applicable laws and regulations. Any loss or profit sustained as a consequence of any such over-allotment

or stabilization shall be for the account of the Stabilizing Manager. The Stabilizing Manager may conduct these transactions in the over-the-counter

market or otherwise. If the Stabilizing Manager commences any stabilization action, it may discontinue them at any time. Nothing contained

in this paragraph shall be construed so as to require the Company to issue in excess of €500,000,000 in aggregate principal amount

of the 2028 Notes, €500,000,000 in aggregate principal amount of the 2031 Notes or €500,000,000 in aggregate principal amount

of the 2034 Notes. The Company will not take, directly or indirectly, any action designed to or that would reasonably be expected to

cause or result in any stabilization or manipulation of the price of the Securities.

26.          Recognition

of the U.S. Special Resolution Regimes.

(a)          In

the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer

from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent

as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation,

were governed by the laws of the United States or a state of the United States.

(b) In the event that

any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special

Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to

no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed

by the laws of the United States or a state of the United States.

section:

“BHC Act Affiliate”

has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).

“Covered Entity”

means any of the following:

(i) a “covered

entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);

(ii) a “covered

bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or

(iii) a “covered

FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).

“Default Right”

has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1,

as applicable.

“U.S. Special Resolution

Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title

II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.

27.          Solely

for the purposes of the requirements of Article 9(8) of the MiFID Product Governance rules under EU Delegated Directive

2017/593, as amended (the “MiFID II Product Governance Rules”) regarding the mutual responsibilities of manufacturers under

the MiFID II Product Governance Rules: (i) Deutsche Bank AG, London Branch (the “EU Manufacturer”) acknowledges that

it understands the responsibilities conferred upon it under the MiFID II Product Governance Rules relating to each of the product

approval process, the target market and the proposed distribution channels as applying to the Securities and the related information

set out in the Prospectus and any announcements in connection with the Securities; and (ii) the Underwriters (other than the EU

Manufacturer) and the Company each note the application of the MiFID II Product Governance Rules and each acknowledge the target

market and distribution channels identified as applying to the Securities by the EU Manufacturer and the related information set out

in the Prospectus and any announcements in connection with the Securities.

Solely for the purposes of

the requirements of 3.2.7R of the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance

Rules”) regarding the mutual responsibilities of manufacturers under the UK MiFIR Product Governance Rules: (i) each of Deutsche

Bank AG, London Branch, Merrill Lynch International, Citigroup Global Markets Limited and J.P. Morgan Securities plc (each a “UK

Manufacturer” and together the “UK Manufacturers”) acknowledges to each other UK Manufacturer that it understands the

responsibilities conferred upon it under the UK MiFIR Product Governance Rules relating to each of the product approval process,

the target market and the proposed distribution channels as applying to the Securities and the related information set out in the Prospectus

and any announcements in connection with the Securities; and (ii) the Underwriters (other than the UK Manufacturers) and the Company

each note the application of the UK MiFIR Product Governance Rules and each acknowledge the target market and distribution channels

identified as applying to the Securities by the UK Manufacturers and the related information set out in the Prospectus and any announcements

in connection with the Securities.

[Signature Page Follows]

If the foregoing is in accordance with your understanding,

please sign and return to us a counterpart hereof, whereupon this letter and the acceptance by you thereof shall constitute a binding

agreement between the Company and you in accordance with its terms.

Very truly yours,

3M Company

By:

/s/

Anurag Maheshwari

Name:

Anurag Maheshwari

Title:

Executive Vice President and Chief Financial Officer

By:

/s/ Stephanie Jones

Name:

Stephanie Jones

Title:

Senior Vice President, Tax and Treasurer

[Signature Page to

the Underwriting Agreement]

Accepted as of the date hereof:

By: DEUTSCHE BANK AG, LONDON BRANCH

By:

/s/ Ritu Ketkar

Name: Ritu Ketkar

Title: Managing Director

By:

/s/ Andres Copete

Name: Andres Copete

Title: Managing Director

By: MERRILL LYNCH INTERNATIONAL

By:

/s/Angus Reynolds

Name: Angus Reynolds

Title: Managing Director

By: CITIGROUP GLOBAL MARKETS LIMITED

By:

/s/ Abraham Omotoso

Name: Abraham Omotoso

Title: Designated Signatory

By:

J.P. MORGAN SECURITIES PLC

By:

/s/ Robert Chambers

Name: Robert Chambers

Title: Executive Director

[Signature Page to the Underwriting Agreement]

By: BARCLAYS BANK PLC

By:

/s/

Emily Wilson

Name: Emily Wilson

Title: Authorized Signatory

By: BNP PARIBAS

By:

/s/

Rafael Ribeiro

Name: Rafael Ribeiro

Title: Managing Director, Head of Investment Grade

Finance, Americas

By:

/s/

Christian Stewart

Name: Christian Stewart

Title: Managing Director

By: GOLDMAN SACHS & CO. LLC

By:

/s/ Jonathan Zwart

Name: Jonathan Zwart

Title: Managing Director

By: MORGAN STANLEY & CO. INTERNATIONAL PLC

By:

/s/ Kathryn McArdle

Name: Kathryn McArdle

Title: Executive Director

By: WELLS FARGO SECURITIES INTERNATIONAL LIMITED

By:

/s/ Bradley Cooper

Name: Bradley Cooper

Title: Executive Director

[Signature Page to the Underwriting Agreement]

By: ACADEMY SECURITIES, INC.

By:

/s/ Anthony Johnson

Name: Anthony Johnson

Title: Compliance Analyst

By: BANCO SANTANDER, S.A.

By:

/s/ Matthias d’Haene

Name: Matthias d’Haene

Title: DCM Executive Director

By:

/s/ Alexis Rohr

Name: Alexis Rohr

Title: DCM VP

By: BNY MELLON CAPITAL MARKETS, LLC

By:

/s/ Dan Klinger

Name: Dan Klinger

Title: Managing Director

By: ICBC STANDARD BANK PLC

By:

/s/ Philip Hurley

Name: Philip Hurley

Title: Head of Global Markets

By:

/s/ David Guthrie

Name: David Guthrie

Title: Legal Department

By: LOOP CAPITAL MARKETS LLC

By:

/s/ Omar F. Zaman

Name: Omar F. Zaman

Title: Managing Director & Head of Coverage and Debt Finance

[Signature Page to the Underwriting Agreement]

By: PNC CAPITAL MARKETS LLC

By:

/s/ Lauren Neugebauer Wagner

Name: Lauren Neugebauer Wagner

Title: Senior Associate

By: RBC EUROPE LIMITED

By:

/s/ Elaine S. Murray

Name: Elaine S. Murray

Title: Duly Authorized Signatory

By: STANDARD CHARTERED BANK

By:

/s/ Patrick Dupont-Liot

Name: Patrick Dupont-Liot

Title: Managing Director, Debt Capital Markets

By: U.S. BANCORP INVESTMENTS, INC.

By:

/s/ Charles P. Carpenter

Name: Charles P. Carpenter

Title: Senior Vice President

[Signature Page to the Underwriting Agreement]

SCHEDULE I

Underwriters

Aggregate

Principal Amount of

2028 Notes to be

Purchased

Aggregate

Principal Amount of

2031 Notes to be

Purchased

Aggregate

Principal Amount of

2034 Notes to be

Purchased

Deutsche Bank AG, London Branch

€ 82,500,000

Merrill Lynch International

82,500,000

Citigroup Global Markets Limited

82,500,000

J.P. Morgan Securities plc

82,500,000

Barclays Bank PLC

25,000,000

BNP PARIBAS

25,000,000

Goldman Sachs & Co. LLC

25,000,000

Morgan Stanley & Co. International plc

25,000,000

Wells Fargo Securities International Limited

25,000,000

Academy Securities, Inc.

5,000,000

Banco Santander, S.A.

5,000,000

BNY Mellon Capital Markets, LLC

5,000,000

ICBC Standard Bank Plc

5,000,000

Loop Capital Markets LLC

5,000,000

PNC Capital Markets LLC

5,000,000

RBC Europe Limited

5,000,000

Standard Chartered Bank

5,000,000

U.S. Bancorp Investments, Inc.

5,000,000

Total

€ 500,000,000

Sch-I

SCHEDULE II

· Final

Term Sheet, dated September 3, 2026, for the 3.500% Notes due 2028, the 3.900% Notes

due 2031 and the 4.100% Notes due 2034.

Sch-II

SCHEDULE III

· Investor

Presentation, dated September 2026.

Sch-III

EX-4.1 — EXHIBIT 4.1

EX-4.1

Filename: tm2624999d1_ex4-1.htm · Sequence: 3

Exhibit 4.1

(Face of Security)

3.500% NOTES DUE 2028

THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE

HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A COMMON DEPOSITARY (THE “COMMON DEPOSITARY”) FOR CLEARSTREAM

BANKING S.A. (“CLEARSTREAM”) AND EUROCLEAR BANK SA/NV (“EUROCLEAR” AND, TOGETHER WITH CLEARSTREAM,

“EUROCLEAR/CLEARSTREAM”) OR A NOMINEE THEREOF.

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE

OF EUROCLEAR/CLEARSTREAM TO 3M COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED

IN THE NAME OF THE BANK OF NEW YORK DEPOSITORY (NOMINEES) LIMITED, AS NOMINEE OF THE BANK OF NEW YORK MELLON, LONDON BRANCH OR IN SUCH

OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY FOR EUROCLEAR/CLEARSTREAM (AND ANY PAYMENT IS MADE TO

THE BANK OF NEW YORK DEPOSITORY (NOMINEES) LIMITED, AS NOMINEE OF THE BANK OF NEW YORK MELLON, LONDON BRANCH OR TO SUCH OTHER ENTITY AS

IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY FOR EUROCLEAR/CLEARSTREAM), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF

FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, THE BANK OF NEW YORK DEPOSITORY (NOMINEES)

LIMITED, AS NOMINEE OF THE BANK OF NEW YORK MELLON, LONDON BRANCH OR SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE

OF THE COMMON DEPOSITARY FOR EUROCLEAR/CLEARSTREAM, HAS AN INTEREST HEREIN. UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR

SECURITIES IN CERTIFICATED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE COMMON DEPOSITARY TO A NOMINEE OF

THE COMMON DEPOSITARY, BY A NOMINEE OF THE COMMON DEPOSITARY TO THE COMMON DEPOSITARY OR ANOTHER NOMINEE OF THE COMMON DEPOSITARY, OR

BY THE COMMON DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR COMMON DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR COMMON DEPOSITARY.

R-1

CUSIP NO.: 88579Y BS9

ISIN NO.: XS3460877650

COMMON CODE: 346087765

3M COMPANY

3.500% NOTES DUE 2028

The following terms apply to this Security, as

and to the extent shown below:

PRINCIPAL AMOUNT: €500,000,000

INTEREST RATE: 3.500% per annum

STATED MATURITY DATE: September 10, 2028

INTEREST PAYMENT DATES: Payable annually on September 10 of each year, beginning September 10, 2027

SPECIFIED CURRENCY: Euro

REGULAR RECORD DATES: (i) in the case of the Securities represented by this Security, at the close of business on the Clearing System Business Day immediately preceding each Interest Payment Date and (ii) in all other cases, 15 calendar days prior to each Interest Payment Date.

ORIGINAL ISSUE DATE: September 10, 2026

OTHER TERMS: Optional Make-Whole Redemption; Redemption for Tax Reasons. See Addendum attached hereto.

DEFEASANCE:

Full Defeasance:  Applicable

Covenant Defeasance: Applicable

Whenever used in this Security, the terms specified above that apply

to this Security have the meanings specified above, unless the context requires otherwise. Other terms used in this Security that are

not defined herein but that are defined in the Indenture referred to in Section 1 on the reverse of this Security are used herein

as defined therein.

3M Company, a corporation duly organized and existing

under the laws of the State of Delaware (hereinafter called the “Company”, which term includes any successor Person

under the Indenture), for value received, hereby promises to pay to The Bank of New York Depository (Nominees) Limited, as nominee of

The Bank of New York Mellon, London Branch as common depositary for Clearstream Banking S.A. and Euroclear Bank SA/NV, or registered assigns,

as principal the Principal Amount on the Stated Maturity Date and to pay interest thereon, at the Interest Rate shown above (computed

on the basis of the actual number of days in the period for which interest is being calculated divided by the actual number of days from

and including the last date on which interest was paid on this Security (or the Original Issue Date, if no interest has been paid on this

Security), to, but not including, the next scheduled Interest Payment Date (such payment convention being referred to as ACTUAL/ACTUAL

(ICMA)), annually in arrears on each Interest Payment Date set forth above from and after the date of this Security and at Maturity until

payment of the principal amount hereof has been made or duly provided for. Each payment of interest due on an Interest Payment Date or

the date of Maturity will include interest accrued from and including the last date to which interest has been paid, or made available

for payment, or from the Original Issue Date if none has been paid, or made available for payment, to but excluding the Interest Payment

Date or the date of Maturity, as the case may be. Unless this Security is a Security which has been issued upon transfer of, in exchange

for, or in replacement of, a Predecessor Security, interest on this Security shall accrue from the Original Issue Date indicated above.

If this Security has been issued upon transfer of, in exchange for, or in replacement of, a Predecessor Security, interest on this Security

shall accrue from the last Interest Payment Date to which interest was paid on such Predecessor Security or, if no interest was paid on

such Predecessor Security, from the Original Issue Date indicated above. Any premium and any such installment of interest that is overdue

at any time shall also bear interest (to the extent that the payment of such interest shall be legally enforceable), at the rate per annum

at which the principal then bears interest, from the date any such overdue amount first becomes due until it is paid or made available

for payment. Notwithstanding the foregoing, interest on any principal, premium or installment of interest that is overdue shall be payable

on demand.

The interest so payable, and punctually paid or

duly provided for, on any Interest Payment Date will, as provided in the Indenture, be paid to the Person in whose name this Security

(or one or more Predecessor Securities) is registered at the close of business on the applicable Regular Record Date specified on the

face hereof. If interest is due at Maturity but on a day that is not an Interest Payment Date, interest will be paid to the Person entitled

to receive the principal hereof. Any interest so payable, but not punctually paid or duly provided for, on any Interest Payment Date will

forthwith cease to be payable to the Holder on such Regular Record Date and such Defaulted Interest either may be paid to the Person in

whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the

payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to the Holder of this Security not less than

10 days prior to such Special Record Date, or may be paid in any other lawful manner not inconsistent with the requirements of any securities

exchange on which this Security may be listed, and upon such notice as may be required by such exchange, all as more fully provided in

the Indenture.

Currency of Payment

Payment of principal of (and premium, if any) and

interest on this Security will be made in the Specified Currency for such payment. The Specified Currency for any payment shall be the

currency specified as such on the face of this Security. If the euro is unavailable to the Company due to the imposition of exchange controls

or other circumstances beyond the Company’s control or if the euro is no longer being used by the then member states of the European

Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within

the international banking community, then all payments in respect of this Security will be made in U.S. dollars until the euro is again

available to the Company or so used.

The amount payable on any date in euro will be

converted into U.S. dollars at the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second Business

Day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis

of the most recent U.S. dollar/euro exchange rate published in The Wall Street Journal on or prior to the second Business Day prior to

the relevant payment date. Any payment in respect of this Security so made in U.S. dollars will not constitute an Event of Default under

this Security or the Indenture. Neither the Trustee nor the Paying Agent will have any responsibility for any calculation or conversion

in connection with the foregoing.

The Company has initially appointed The Bank of

New York Mellon, London Branch, as paying agent with respect to this Security (in such capacity, together with any successor thereto,

the “Paying Agent”).

Manner of Payment

Payments in respect of this Security (including

principal, premium, if any, interest and additional amounts, if any) will be made to the Paying Agent one Business Day prior to the date

such payment is due. The Paying Agent will then make such payments to Clearstream and Euroclear, which will in turn distribute such payments

to their participants in accordance with their respective procedures. After payment to the Paying Agent, neither the Company nor the Trustee

will have any responsibility or liability for the payment of interest, principal or other amounts to the owners of beneficial interests

in this Security.

Manner of Payment - Global Securities

Notwithstanding any provision of this Security

or the Indenture, if this Security is a Global Security, the Company may make any and all payments of principal, premium and interest

on this Security pursuant to the applicable policies of Euroclear and Clearstream for this Security as permitted in the Indenture.

Payments Due on a Business Day

Unless otherwise specified on the face of this

Security, the following provisions shall apply to this Security. Notwithstanding any provision of this Security or the Indenture, if any

date on which interest is payable on this Security (other than the Stated Maturity Date or any earlier date of redemption) is not a Business

Day, the payment of the interest payable on that date will be made on the next succeeding Business Day with the same force and effect

as if made on the scheduled payment date. If the Stated Maturity Date or any earlier date of redemption of this Security is not a Business

Day, the required payment will be made on the next succeeding Business Day as if it were made on the date such payment was due and no

additional interest will accrue on the amount so payable for the period from and after the Stated Maturity Date or such date of redemption,

as the case may be. The provisions of this paragraph shall apply to this Security in lieu of the provisions of Section 113 of the

Indenture.

Reference is hereby made to the further provisions

of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth

at this place.

Unless the certificate of authentication hereon

has been executed by the Trustee by manual or electronic signature, this Security shall not be entitled to any benefit under the Indenture

or be valid or obligatory for any purpose.

IN WITNESS WHEREOF, the Company has caused this

instrument to be duly executed

3M COMPANY

By:

Name:

Anurag Maheshwari

Title:

Executive Vice President and Chief Financial Officer

By:

Name:

Stephanie Jones

Title:

Senior Vice President, Tax and Treasurer

This is one of the Securities of the series designated

herein and referred to in the Indenture.

Date: September 10, 2026

The

Bank of New York Mellon Trust Company, N.A., as Trustee

By:

Authorized Signatory

(Reverse of Security)

1. Securities and Indenture.

This Security is one of a duly authorized issue of

securities of the Company (herein called the “Securities”) issued and to be issued in one or more series under an Indenture,

dated as of November 17, 2000 as amended by the First Supplemental Indenture, dated July 29, 2011, and the Second Supplemental

Indenture, dated February 3, 2026, as further amended or supplemented from time to time (herein called the “Indenture”,

which term shall have the meaning assigned to it in such instrument), between the Company and The Bank of New York Mellon Trust Company,

N.A., as Trustee (herein called the “Trustee”, which term includes any successor trustee under the Indenture), and

reference is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder

of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated

and delivered.

2. Series and Denominations.

This Security is one of the series designated on

the face hereof, limited to an aggregate principal amount not to exceed €500,000,000 (or the equivalent thereof in any other currency

or currencies or currency units), which amount may be increased at the option of the Company if in the future it determines that it may

wish to sell additional Securities of this series. References herein to “this series” mean the series of securities

designated on the face hereof.

The Company may, from time to time, without the

consent of or notice to existing Holders of the Securities, create and issue additional Securities with the same terms and conditions

as this Security in all respects, except for the issue date, issue price and, to the extent applicable, the first payment of interest.

Additional Securities issued in this manner will be consolidated with and will form a single series with the Securities of this series,

unless the additional Securities are not fungible for U.S. federal income tax or securities law purposes with such series.

The Securities of this series are issuable only in

registered form without coupons in “Authorized Denominations”, which term shall have the following meaning. Unless

otherwise specified, for each Security of this series, the Authorized Denominations shall be €100,000 and integral multiples of €1,000

in excess thereof.

3. Interest Rate.

(a)           Calculation

of Interest. Payments of interest hereon with respect to any Interest Payment Date or at the Maturity of the principal hereof

will include interest accrued to but excluding such Interest Payment Date or the date of such Maturity, as the case may be. Interest

will be computed on the basis of the actual number of days in the period for which interest is being calculated divided by the actual

number of days from and including the last date on which interest was paid on this Security (or the Original Issue Date, if no interest

has been paid on this Security), to, but not including, the next scheduled Interest Payment Date (such payment convention being referred

to as ACTUAL/ACTUAL (ICMA)).

All calculations to be made with respect to this

Security will be made by the Company. All percentages resulting from any calculation with respect to this Security will be rounded upward

or downward, as appropriate, to the next higher or lower one hundred- thousandth of a percentage point (e.g., 9.876541% (or .09876541)

being rounded down to 9.87654% (or .0987654) and 9.876545% (or .09876545) being rounded up to 9.87655% (or .0987655) ). All amounts used

in or resulting from any calculation with respect to this Security will be rounded upward or downward, as appropriate, to the nearest

euro cent, with one-half euro cent or more being rounded upward.

(b)           Definitions

of Terms. As used in this Security, the following terms have the meanings set forth below:

“Business Day” means, for this

Security, any day, other than a Saturday or Sunday, (i) which is not a day on which banking institutions in the City of New York

or the City of London are authorized or required by law or executive order to close and (ii) on which the T2 system, or any successor

thereto, operates.

“Clearing System Business Day”

means every Monday to Friday, inclusive, except December 25th and January 1st, subject to certain exceptions.

“T2 system” means the Trans-European

Automated Real-time Gross Settlement Express Transfer payment system or any successor of, or replacement for, that system.

References in this Security to “€”

or “euro” shall mean, as of any time, the lawful currency of the member states of the European Union that have adopted

or adopt the single currency in accordance with the Treaty on the Functioning of the European Union, as amended.

Agent. Initially, The Bank of New York Mellon, London Branch, will act as Paying Agent. The Company may change any

Paying Agent without notice to the Holders. Payment of the principal, premium, if any, and interest on the Securities of this series will

be made at the office or agency maintained for that purpose in London (initially the corporate trust office of the Paying Agent). Initially,

The Bank of New York Mellon Trust Company, N.A. will act as Registrar and Transfer Agent.

4. Redemption at the Company’s Option.

This Security shall not be redeemable, except as

set forth in the Addendum attached hereto.

5. Payment of Additional Amounts.

The Company will, subject to the exceptions and limitations

set forth below, pay as additional interest on this Security such additional amounts as are necessary in order that the net payment by

the Company or the Paying Agent of the principal, premium, if any, and interest with respect to this Security to a beneficial owner, after

withholding or deduction for any present or future tax, assessment, or other governmental charge imposed by the United States or a taxing

authority in the United States or any jurisdiction in which the Company (or any successor) is organized or resident for tax purposes (each,

a “Tax Jurisdiction”) will not be less than the amount provided in this Security to be then due and payable; provided,

however, that the foregoing obligation to pay additional amounts will not apply:

i. to any tax, assessment, or other governmental charge that is imposed by reason of the Holder (or the beneficial owner for whose benefit

such Holder holds this Security) or a fiduciary, settlor, beneficiary, member, or shareholder of the Holder, or a person holding a power

over an estate or trust administered by a fiduciary holder, being treated as:

a. being or having been present in, or engaged in a trade or business in, the relevant Tax Jurisdiction, being treated as having been

present in, or engaged in a trade or business in, the relevant Tax Jurisdiction, or having or having had a permanent establishment in

the United States;

b. having a current or former connection with the relevant Tax Jurisdiction (other than a connection arising solely as a result of the

ownership of this Security, the receipt of any payment in respect of this Security, or the enforcement of any rights under the Indenture),

including being or having been a citizen or resident of the United States or treated as being or having been a resident thereof;

c. being or having been a personal holding company, a passive foreign investment company, or a controlled foreign corporation for U.S.

federal income tax purposes, a foreign tax exempt organization, or a corporation that has accumulated earnings to avoid United States

federal income tax;

d. being or having been a “10-percent shareholder”, as defined in Section 871(h)(3) of the United States Internal

Revenue Code of 1986, as amended (the “Code”), or any successor provision, of the Company; or

e. being or having been a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary

course of its trade or business, within the meaning of Section 881(c)(3) of the Code or any successor provision;

ii. to any Holder that is not the sole beneficial owner of this Security, or a portion of this Security, or that is a fiduciary, partnership,

or limited liability company, but only to the extent that a beneficiary or settlor with respect to the fiduciary, a beneficial owner,

or member of the partnership or limited liability company would not have been entitled to the payment of an additional amount had the

beneficiary, settlor, beneficial owner, or member received directly its beneficial or distributive share of the payment;

iii. to any tax, assessment, or other governmental charge that would not have been imposed but for the failure of the holder, beneficial

owner, or any other person to comply with certification, identification, or information reporting requirements concerning the nationality,

residence, identity, or connection with the United States of the holder or beneficial owner of this Security, if compliance is required

by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United

States is a party as a precondition to exemption from such tax, assessment, or other governmental charge (including, for the avoidance

of doubt, any backup withholding tax imposed pursuant to Section 3406 of the Code (or any amended or successor provision) (relating

to backup withholding tax));

iv. to any tax, assessment, or other governmental charge that is imposed otherwise than by withholding by the Company or the Paying Agent

from the payment;

v. to any estate, inheritance, gift, sales, excise, transfer, wealth, capital gains, or personal property tax or similar tax, assessment,

or other governmental charge;

vi. to any tax, assessment or other governmental charge that would not have been imposed but for the presentation by the holder of this

Security, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable

or the date on which payment thereof is duly provided for, whichever occurs later;

vii. to any tax, assessment, or other governmental charge required to be withheld or deducted that is imposed on a payment pursuant to

Sections 1471 through 1474 of the Code (or any amended or successor version of such Sections that is substantively comparable and not

materially more onerous to comply with), any U.S. Treasury regulations promulgated thereunder, or any other official interpretations thereof

(collectively, “FATCA”), any agreement (including any intergovernmental agreement) entered into in connection therewith,

or any law, regulation, or other official guidance enacted in any jurisdiction implementing FATCA or an intergovernmental agreement in

respect of FATCA;

viii. to any tax, assessment, or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation,

or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided

for, whichever occurs later;

ix. to any tax, assessment, or other governmental charge imposed by reason of the failure of the beneficial owner to fulfill the statement

requirements of Section 871(h) or Section 881(c) of the Code;

x. to any tax imposed pursuant to Section 871(h)(6) or 881(c)(6) of the Code (or any amended or successor provisions);

xi. to any tax imposed as a result of any combination of items (i) through (x).

Except as specifically provided above, the Company

will not be required to pay additional amounts in respect of any tax, assessment, or other governmental charge. References in this Security

to any payment on this Security include the related payment of additional amounts, as applicable.

As used herein, the term “United States”

means the United States of America, any state thereof, and the District of Columbia.

6. Transfer and Exchange.

As provided in the Indenture and subject to certain

limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security

for registration of transfer at the office or agency of the Company at the office of the Paying Agent in London, duly endorsed by, or

accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder

hereof or his or her attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor and

terms, of Authorized Denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees.

As provided in the Indenture and subject to certain

limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this

series and of like tenor of a different Authorized Denomination, as requested by the Holder surrendering the same.

No service charge shall be made for any such registration

of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable

in connection therewith.

Prior to due presentment of this Security for registration

of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Security is

registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company nor the Trustee nor

any such agent shall be affected by notice to the contrary.

If this Security is a Global Security, this Security

shall be subject to the provisions of the Indenture relating to Global Securities, including the limitations in Section 305 thereof

on transfers and exchanges of Global Securities. In addition to the provisions of Section 305 of the Indenture, if at any time an

Event of Default has occurred and is continuing with respect to this Security and such Event of Default has not been cured or waived pursuant

to the provisions of the Indenture, the Company will execute, and the Trustee, upon receipt of a Company Order for the authentication

and delivery of definitive Securities, will authenticate and deliver, Securities in definitive form and in an aggregate principal amount

equal to the principal amount of the Global Security or Securities in exchange for such Global Security or Securities.

7. Defeasance.

The Indenture contains provisions for defeasance

at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security,

in each case upon compliance with certain conditions set forth in the Indenture. If so specified on the face hereof, either or both of

such provisions are applicable to this Security, as so specified.

8. Remedies.

If an Event of Default with respect to Securities

of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner

and with the effect provided in the Indenture.

No reference herein to the Indenture and no provision

of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay

the principal of (and premium, if any) and interest on this Security at the times, place and rate, and in the coin or currency, herein

prescribed.

9. Modification and Waiver.

The Indenture permits, with certain exceptions as

therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders

of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the

Holders of a majority in aggregate principal amount of the Securities at the time Outstanding of each series to be affected.

Under the Indenture, the Holders of a majority in

aggregate principal amount of the Outstanding Securities of this series or any other series of Outstanding Securities may, on behalf of

all Holders of that series, waive compliance by the Company with certain restrictive covenants of the Indenture, and waive any past Event

of Default under the Indenture, but in each case only with respect to that series, except an Event of Default in the payment of the principal

of or any premium or interest on and Securities of that series or an Event of Default under any provision of the Indenture which itself

cannot be modified or amended without the consent of the holders of each Outstanding Security of that series. Any such consent or waiver

by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any

Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent

or waiver is made upon this Security.

10. Governing Law.

This Security and the Indenture shall be governed

by and construed in accordance with the laws of the State of New York.

ABBREVIATIONS

The following abbreviations, when used in the inscription

on the face of this Security, shall be construed as though they were written out in full according to applicable laws or regulations.

TEN COM – as tenants in common

TEN ENT – as tenants by the entireties

JT TEN – as joint tenants with the right of survivorship

and not as tenants in common

UNIF GIFT MIN ACT - Custodian

(Cust)

(Minor)

Under Uniform Gifts to Minors Act

(State)

Additional Abbreviations may also be used though not in the above list

ASSIGNMENT

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto

PLEASE INSERT SOCIAL SECURITY OR OTHER

IDENTIFYING NUMBER OF ASSIGNEE

(Please Print or typewrite Name and Address

Including Postal Zip Code of Assignee)

The attached Security and all rights thereunder, and hereby irrevocably constitutes and appoints

to transfer said Security on the books of the Company, with full power of the substitution in the premises.

Dated: __________________

Signature Guaranteed

NOTICE: Signature must be guaranteed.

NOTICE: The signature to this assignment must correspond with the name of the Holder as written upon the face of the attached Security in every particular, without alteration or enlargement or any change whatever.

ADDENDUM

Optional Make-Whole Redemption

The Company may redeem this Security at its option,

in whole or in part, at any time and from time to time prior to the Stated Maturity Date, at a redemption price equal to the greater of:

(a) 100% of the principal amount of this Security

to be redeemed, and

(b) the sum of the present values of the remaining

scheduled payments of principal and interest on this Security to be redeemed (exclusive of interest accrued to the redemption date), discounted

to the redemption date on an annual basis (ACTUAL/ACTUAL (ICMA)), at the applicable Comparable Government Bond Rate (as defined below)

plus 10 basis points,

plus, in each case, accrued and unpaid interest

thereon, if any, to, but not including, the redemption date.

If money sufficient to pay the redemption price

of and accrued interest on this Security (or the portion hereof) to be redeemed on the redemption date is deposited with the Trustee or

the Paying Agent on or before 11:00 a.m., New York City time, on the redemption date and certain other conditions are satisfied, then

on and after the redemption date, interest will cease to accrue on this Security (or such portion hereof) called for redemption and this

Security (or such portion hereof) will cease to be outstanding. If any redemption date is not a Business Day, the Company will pay the

redemption price on the next Business Day without any additional interest or other payment due to the delay.

“Comparable Government Bond”

means, in relation to any Comparable Government Bond Rate calculation, the German government bond (Bundesanleihe) selected by an

Independent Investment Banker as having an actual or interpolated maturity comparable to the remaining term of this Security to be redeemed

that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of euro-denominated

corporate debt securities of a comparable maturity to the remaining term of this Security.

“Comparable Government Bond Price”

means, with respect to any redemption date, (i) the arithmetic average of the Reference Government Bond Dealer Quotations for such

redemption date, after excluding the highest and lowest such Reference Government Bond Dealer Quotations, or (ii) if the Company

obtains fewer than four such Reference Government Bond Dealer Quotations, the arithmetic average of all such quotations.

“Comparable Government Bond Rate”

means, with respect to any redemption date, the rate per annum equal to the yield to maturity, expressed as a percentage (rounded to three

decimal places, with 0.0005 being rounded upwards), on the third Business Day prior to the date fixed for redemption, calculated in accordance

with customary financial practice in pricing new issues of comparable corporate debt securities paying interest on an annual basis (ACTUAL/ACTUAL

(ICMA)) of the Comparable Government Bond, assuming a price for the Comparable Government Bond (expressed as a percentage of its principal

amount) equal to the Comparable Government Bond Price for such redemption date.

“Independent Investment Banker”

means one of the Reference Government Bond Dealers selected by the Company.

“Reference Government Bond Dealer”

means (i) each of Deutsche Bank AG, London Branch, Merrill Lynch International, Citigroup Global Markets Limited and J.P. Morgan

Securities plc or any of their affiliates that are primary European government securities dealers, and their respective successors; provided

that if any of the foregoing or any of their affiliates shall cease to be a primary European government securities dealer (a “Primary

Dealer”), the Company shall substitute therefor another Primary Dealer and (ii) two other Primary Dealers selected by the

Company.

“Reference Government Bond Dealer Quotations”

means, with respect to each Reference Government Bond Dealer and any redemption date, the arithmetic average, as determined by the Company,

of the bid and asked prices for the Comparable Government Bond (expressed in each case as a percentage of its principal amount) quoted

in writing to the Company by such Reference Government Bond Dealer at 11:00 a.m., Central European Time (CET), on the third Business Day

preceding such redemption date.

The Company’s actions and determinations

in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error. The Trustee shall have no

duty to calculate the redemption price.

Notice of any redemption pursuant to this heading

“Optional Make-Whole Redemption and Redemption at Par Prior to Maturity” will be mailed or electronically delivered (or otherwise

transmitted in accordance with the depositary’s procedures) at least 10 days but not more than 60 days before the redemption date

to each Holder of this Security to be redeemed.

In the case of a partial redemption, selection

of this Security for redemption will be made pro rata, by lot or by such other applicable method. No Securities of a principal amount

of €100,000 or less will be redeemed in part. If this Security is to be redeemed in part only, the notice of redemption that relates

to this Security will state the portion of the principal amount of this Security to be redeemed. A new Security in a principal amount

equal to the unredeemed portion of this Security will be issued in the name of the Holder of this Security upon surrender for cancellation

of the original Security. For so long as this Security is held by Euroclear or Clearstream (or another depositary), the redemption of

this Security shall be done in accordance with the policies and procedures of the depositary.

Notice of any redemption of this Security in connection

with a transaction or an event may, at the Company’s discretion, be given prior to the completion or the occurrence thereof. Any

redemption or notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited

to, completion or occurrence of a related transaction or event. At the Company’s discretion, the redemption date may be delayed

until such time as any or all such conditions shall be satisfied, or such redemption may not occur and such notice may be rescinded in

the event that any or all such conditions shall not have been satisfied by the redemption date, or by the redemption date as so delayed.

The Company will provide written notice to the Trustee prior to the close of business two Business Days prior to the redemption date if

any such redemption has been rescinded or delayed, and upon receipt the Trustee will provide such notice to each Holder of this Security

to be redeemed in the same manner in which the notice of redemption was given.

Unless the Company defaults in payment of the

redemption price, on and after the redemption date interest will cease to accrue on this Security, or portions hereof, called for redemption.

Redemption for Tax Reasons

If, as a result of any change in, or amendment

to, the laws (or any regulations or rulings promulgated under the laws) of the relevant Tax Jurisdiction (as defined on the reverse of

this Security) or any change in, or amendments to, an official position regarding the application, interpretation, administration, or

enforcement thereof (including by virtue of any action taken by a taxing authority, a holding, judgment, or order by a court of competent

jurisdiction (whether or not such action was taken or brought with respect to the Company), or a change in published administrative practice)

that is announced and/or becomes effective on or after September 3, 2026 (or, if the Tax Jurisdiction is not the United States, after

the date such Tax Jurisdiction became a Tax Jurisdiction), based upon a written opinion of independent counsel selected by the Company,

the Company becomes or will become obligated to pay additional amounts as described on the reverse of this Security under the heading

“Payment of Additional Amounts” with respect to this Security, then the Company may at any time at its option redeem this

Security, in whole, but not in part, on not less than 10 nor more than 90 days’ prior notice, at a redemption price equal to 100%

of the principal amount of this Security, plus accrued and unpaid interest, if any (including, for the avoidance of doubt, any additional

amounts), to, but not including, the redemption date.

The Company will not give any such notice of redemption

earlier than 90 days prior to the earliest date on which the Company would be obligated to pay additional amounts if a payment in respect

of this Security was then due, and the law giving rise to the obligation to pay additional amounts (whether the obligation to withhold

is then effective or will become effective after the notice) must be in effect at the time such notice is given.

EX-4.2 — EXHIBIT 4.2

EX-4.2

Filename: tm2624999d1_ex4-2.htm · Sequence: 4

Exhibit 4.2

(Face of Security)

3.900% NOTES DUE 2031